You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
PAI Holdings LLCFDAMed source confidence · 83%Jun 30, 2026, 1:02 AM UTC · 8d ago

PAI Holdings LLC — FDA Class II (D-0591-2026)

Case File

PAI Holdings LLC is recalling a drug due to non-compliance with USP or OTC monograph standards. This recall is classified as a voluntary action. Specific quantities and geographic scope were not provided.

Sign in to follow PAI Holdings LLC and get alerts like this
Key Points
  • PAI Holdings LLC is recalling a drug for safety standard violations.
  • The product does not meet USP or OTC monograph requirements.
  • This is a voluntary recall with no specific quantities provided.
  • Consumers should check their medicine cabinets for this product.
Why This Matters

Consumers using this drug may be at risk due to safety standard violations. They should stop using the product immediately.

View original filing →
Sign in to follow PAI Holdings LLC and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.